Cargando…
Pneumococcal Vaccination in Immunocompromised Hosts: An Update
Infections with the pathogen, Streptococcus pneumoniae, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination s...
Autores principales: | Froneman, Claire, Kelleher, Peter, José, Ricardo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223771/ https://www.ncbi.nlm.nih.gov/pubmed/34063785 http://dx.doi.org/10.3390/vaccines9060536 |
Ejemplares similares
-
HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017) -
Sporotrichosis In Immunocompromised Hosts
por: Queiroz-Telles, Flavio, et al.
Publicado: (2019) -
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
por: Chilson, Erica, et al.
Publicado: (2020) -
Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
por: Bukan, Katrine, et al.
Publicado: (2023) -
Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)